Get the Stockscreener App
7.20
1.89%
-0.139
Leverage Shares 2 X Long Grab Daily Etf stock is traded at $7.20, with a volume of 5,751.
It is down -1.89% in the last 24 hours and down -20.46% over the past month.
See More
Previous Close:
$7.339
Open:
$7.38
24h Volume:
5,751
Relative Volume:
0.77
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-13.82%
1M Performance:
-20.46%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$7.20
$7.4601
1-Week Range:
$7.20
$8.38
52-Week Range:
$7.20
$15.35
Leverage Shares 2 X Long Grab Daily Etf Stock (GRAG) Company Profile
Name
Leverage Shares 2 X Long Grab Daily Etf
Sector
Industry
Phone
-
Address
-
Compare GRAG vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAG
Leverage Shares 2 X Long Grab Daily Etf
|
7.20 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
662.29 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Leverage Shares 2 X Long Grab Daily Etf Stock (GRAG) Latest News
This Steel Stock Just Hiked its Dividend by 6%, Is it a Buy Now? - Barchart.com
Stitch Fix (SFIX) To Report Earnings Tomorrow: Here Is What To Expect - Barchart.com
FOMO Trade: Can Grab Holdings Limited Equity Warrant beat the S P 5002026 Movers & Verified Momentum Stock Ideas - baoquankhu1.vn
Stocks in play: GoldHaven Resources Corp - Barchart.com
Glaucoma Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire Pharma, Kowa - Barchart.com
6 Best Defense ETFs to Buy in 2026 - The Motley Fool
Leverage Shares 2X Long GRAB Daily ETF (GRAG.US) Latest News & Headlines - Longbridge
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeutics, AstraZeneca - Barchart.com
Best Buy (BBY) Reports Earnings Tomorrow: What To Expect - Barchart.com
What To Expect From MongoDB’s (MDB) Q4 Earnings - Barchart.com
Uber Air Is Officially Here. Does That Make Uber Stock a Buy on Flying Car Dreams? - Barchart.com
Installed Building Products (IBP) Reports Q4: Everything You Need To Know Ahead Of Earnings - Barchart.com
Celsius (CELH) Q4 Earnings: What To Expect - Barchart.com
Natera Earnings: What To Look For From NTRA - Barchart.com
Hormel Foods (HRL) Q4 Earnings: What To Expect - Barchart.com
Papa John's (PZZA) Q4 Earnings: What To Expect - Barchart.com
IonQ (IONQ) Q4 Earnings Report Preview: What To Look For - Barchart.com
Energy Recovery (ERII) Reports Earnings Tomorrow: What To Expect - Barchart.com
Shoals (SHLS) Reports Q4: Everything You Need To Know Ahead Of Earnings - Barchart.com
CAVA (CAVA) Q4 Earnings Report Preview: What To Look For - Barchart.com
Earnings To Watch: Luxfer (LXFR) Reports Q4 Results Tomorrow - Barchart.com
GRAG | Leverage Shares 2X Long Institutional Ownership - Quiver Quantitative
GRAG | Leverage Shares 2X Long Stock Data, Price & News - Quiver Quantitative
Happy Belly Food Group's Heal Wellness Announces the Grand Opening of its 33rd Location in Oakville, Ontario - Barchart.com
CRCA, GRAG: Big ETF Inflows - Nasdaq
As Apple Tests AI Devices, Should You Buy AAPL Stock Here? - Barchart.com
Why Nvidia Just Made a $7.9 Billion Bold Bet on Intel - Barchart.com
Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com
Western Union (WU) Q4 Earnings: What To Expect - Barchart.com
Qualcomm’s Analysts Are Throwing in the Towel—Time to Be Brave? - Barchart.com
Tesla Falters in China Again: How to Play TSLA Stock as Xiaomi Outsells - Barchart.com
Bandwidth (BAND) Q4 Earnings: What To Expect - Barchart.com
Opendoor (OPEN) Reports Earnings Tomorrow: What To Expect - Barchart.com
Earnings To Watch: RE/MAX (RMAX) Reports Q4 Results Tomorrow - Barchart.com
Earn While You Sleep: 3 High-Yield Dividend Stocks to Buy and Hold Forever - Barchart.com
You May Never Have Heard of Corsair Gaming But Its Stock Just Jumped 50%. Should You Buy Shares Here? - Barchart.com
What To Expect From Analog Devices’s (ADI) Q4 Earnings - Barchart.com
NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For - Barchart.com
Toll Brothers (TOL) Q4 Earnings Report Preview: What To Look For - Barchart.com
The Best Inverse ETFs in Canada in April 2025 - Stocktrades
Palantir Just Received DISA Authorization. Does That Make PLTR Stock a Buy, Sell, or Hold? - Barchart.com
Facioscapulohumeral Muscular Dystrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics - Barchart.com
A $100 Million Reason to Buy Intel Stock Now - Barchart.com
Fragile X Syndrome Market to Grow at ~7% CAGR Through 2034 Across 7MM, with 122,000 Diagnosed Cases in 2023 and US Accounting for 58% of Disease Burden | DelveInsight - Barchart.com
Atypical Hemolytic Uremic Syndrome Market: Fast-Growing Therapeutics Outlook by 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, NovelMed Therapeutics - Barchart.com
Super Bowl Sunday Outfits: Comfort and Style That Last From the Living Room to the Backyard with PINSPARK - Barchart.com
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings - Barchart.com
Coinbase (COIN) Reports Q4: Everything You Need To Know Ahead Of Earnings - Barchart.com
Metals Creek Receives 1st Anniversary Payment for the Yellow Fox Property from Lomiko Metals and Adds Claims to Agreement - Barchart.com
Paycom (PAYC) Reports Q4: Everything You Need To Know Ahead Of Earnings - Barchart.com
Darling Ingredients Earnings: What To Look For From DAR - Barchart.com
Leverage Shares 2 X Long Grab Daily Etf Stock (GRAG) Financials Data
There is no financial data for Leverage Shares 2 X Long Grab Daily Etf (GRAG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.14%
1.12%
Cap:
|
Volume (24h):